Experienced in Kaposi Sarcoma

Jun M. Cheng

12 Lingyin Road, 
Hangzhou, CN 
Experienced in Kaposi Sarcoma
12 Lingyin Road, 
Hangzhou, CN 
OverviewLocationsClinical Research

Overview

Jun Cheng practices in Hangzhou, China. Mr. Cheng is rated as an Experienced expert by MediFind in the treatment of Kaposi Sarcoma. His top areas of expertise are Hepatitis B, Hepatitis, Hepatitis C, Liver Transplant, and Endovascular Embolization.

His clinical research consists of co-authoring 681 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Kaposi Sarcoma.

Gender
Male

Locations

12 Lingyin Road, Hangzhou, 310013, China
Other Locations
State Key Laboratory Of Bioreactor Engineering, Shanghai, 200237, China
21 Hengfa Road, Nanjing, China
No. 22 Xingsha Road, Changsha, 410100, China
No. 130, Changjiang West Road, Hefei, 230036, China
14 Lingyin Road, Hangzhou, 310013, China
299 Qingyang Road, Wuxi, 214023, China
8 East Jingshun Street, Beijing, 100015, China
79 QingChun Road, Hangzhou, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Virtual Imaging-based Early Portal Pressure Gradient (vePPG) After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension
Virtual Imaging-based Early Portal Pressure Gradient (vePPG) After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension
Enrollment Status: Withdrawn
Publish Date: January 08, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
Development and Validation of a Radiomics Signature for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1701): a Prospective Multicenter Study
Development and Validation of a Radiomics Signature for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1701): a Prospective Multicenter Study
Enrollment Status: Completed
Publish Date: January 08, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

681 Total Publications

Albuminuria and kidney disease progression in IgA nephropathy in China.
Albuminuria and kidney disease progression in IgA nephropathy in China.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: October 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cheng's expertise for a condition
ConditionClose
    View All 97 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile